Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hemorrhage/fiabhras

Sábháiltear an nasc chuig an gearrthaisce
Leathanach 1 ó 69 torthaí

Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to synthetic soil extract substances comprising phenolic polymers, and to compositions and methods for employing the synthetic phenolic polymers for preventing, reducing, treating, or eliminating hemorrhagic fever viral

Crimean-Congo hemorrhagic fever virus vaccine

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION This application relates generally to the field of viral disease, prophylaxis, and vaccination. More specifically, it provides a virus vaccine modeled on the etiologic agent for Crimean-Congo hemorrhagic fever. It was produced by reducing the deubiquinating and deISGylating

Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED AS AN ASCII TEXT FILE The Sequence Listing written in file U.S. Pat. No. 934,365_ST25.TXT, created on Jul. 7, 2014, 108,900 bytes, machine format IBM-PC, MS-Windows operating system, is hereby incorporated

Dengue hemorrhagic fever virus vaccine

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION The present invention relates to a dengue hemorrhagic fever virus vaccine and compositions thereof and methods of developing the vaccine, to generate an immunity against infection by dengue hemorrhagic fever viruses. The following discussion of the background of the invention

Crimean-congo haemorrhagic fever virus antigenic composition

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
This application is a National Stage Application of PCT/GB2013/053174, filed 29 Nov. 2013, which claims benefit of Serial No. 1303406.1, filed 26 Feb. 2013 in Great Britain and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of

Compositions for use in identification of viral hemorrhagic fever viruses

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION The present invention relates generally to the field of genetic identification and quantification of viruses in the Filoviridae, Flaviviridae, Bunyaviridae and Arenaviridae families and provides methods, compositions and kits useful for this purpose, as well as others, when

Determination of risk of developing dengue hemorrhagic fever/dengue shock syndrome, methods and compositions therefor

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
INTRODUCTION The present Dengue disease is caused by infection with dengue virus (DV), an arthropod-borne virus transmitted by mosquitoes. Dengue virus is classified in the Flaviviridae family, genus Flavivirus. DV has been subdivided into 4 serotypes, DEN-1. DEN-2, DEN-3, and DEN-4. Dengue virus is

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or

Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or
FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated
FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 21, 2011, is named 56441024.txt and is 9,154 bytes in size. FIELD The use of sulfonyl
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 9, 2011, is named 5644102.txt and is 9,265 bytes in size. FIELD OF THE INVENTION The
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 12, 2011, is named 56441026.txt and is 7,802 bytes in size. FIELD The use of sulfonyl
Bí ar ár
leathanach facebook

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht

  • Oibreacha i 55 teanga
  • Leigheasanna luibhe le tacaíocht ón eolaíocht
  • Aitheantas luibheanna de réir íomhá
  • Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
  • Léigh foilseacháin eolaíochta a bhaineann le do chuardach
  • Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
  • Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní

Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe

Google Play badgeApp Store badge